Anti-tumor effects of penfluridol through dysregulation of cholesterol homeostasis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 489-494

  Wu, Lu ^a   Liu, Yan Yang ^a   Li, Zhi Xi ^a   Zhao, Qian ^a   Wang, Xia ^a   Yu, Yang ^a   Wang, Yu Yi ^a   Wang, Yi Qin ^a   Luo, Feng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anti; Antipsychotics drugs; Cholesterol; Penfluridol; tumor effect

Indexed keywords

CHOLESTEROL; NEUROLEPTIC AGENT; PENFLURIDOL;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BREAST TUMOR; C57BL MOUSE; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECT; EXPERIMENTAL MELANOMA; FEMALE; HOMEOSTASIS; LUNG TUMOR; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIPSYCHOTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; COLONIC NEOPLASMS; FEMALE; HOMEOSTASIS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PENFLURIDOL;

EID: 84894051000     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.489     Document Type: Article

References (29)

1. Belkin M, Hardy WG (1957). Effect of reserpine and chlorpromazine on sarcoma 37. Science, 125, 233-4.
2. Catts VS, Catts SV (2000). Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res, 41, 405-15.
3. Cheung NS, Koh CHV, Bay BH, et al (2004). Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons. Biochem Biophys Res Commun, 315, 408-17.
4. Dalton SO, Johansen C, Poulsen AH, et al (2006). Cancer risk among users of neuroleptic medication: a population-based cohort study. Brit J Cancer, 95, 934-9.
5. Freeman MR, Solomon KR (2004). Cholesterol and prostate cancer. J Cell Biochem, 91, 54-69.
6. FDA Guidance for industry and reviewers (2002). Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers, 12.
7. FDA Guidance for Industry food-effect bioavailability and fed bioequivalence studies (2002), 12.
8. Gal G, Goral A, Murad H (2012). Cancer in parents of persons with schizophrenia: Is there a genetic protection? Schizophr Res, 139, 189-93.
9. Gil-Ad I, Shtaif B, Levkovitz Y, et al (2004). Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors. J Mol Neurosci, 22, 189-98.
10. Hait WN, Lee GL (1985). Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Biochem Pharmacol, 34, 3973-8.
11. Kristiana I, Sharpe LJ, Catts VS, et al (2010). Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol. Pharmacogenomics J, 10, 396-407.
12. Lange Y, Steck TL (1994). Cholesterol homeostasis. Modulation by amphiphiles. J Biol Chem, 269, 29371-4.
13. Levin RM, Weiss B (1977). Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol Pharmacol, 13, 690-7.
14. Llaverias G, Danilo C, Mercier I, et al (2011). Role of cholesterol in the development and progression of breast cancer. Am J Pathol, 178, 402-12.
15. Maruoka N, Murata T, Omata N, et al (2007). Effects of chlorpromazine on plasma membrane permeability and fluidity in the rat brain: A dynamic positron autoradiography and fluorescence polarization study. Prog Neuro-Psychoph, 31, 178-86.
16. Mortensen PB (1987). Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr Scand, 75, 585-90.
17. Mortensen PB (1989). The incidence of cancer in schizophrenic patients. J Epidemiol Community Health, 43, 43-7.
18. Mortensen PB (1992). Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr Scand, 85, 390-3.
19. Murata T, Maruoka N, Omata N, et al (2007). A comparative study of the plasma membrane permeabilization and fluidization induced by antipsychotic drugs in the rat brain. Int J Neuropsychopharmacol, 10, 683.
20. Nordenberg J, Fenig E, Landau M, et al (1999). Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Pharmacol, 58, 1229-36.
21. Rybczynska AA, Dierckx RA, Ishiwata K, et al (2008). Cytotoxicity of σ-Receptor Ligands Is Associated with Major Changes of Cellular Metabolism and Complete Occupancy of the σ-2 Subpopulation. J Nucl Med, 49, 2049-56.
22. Sachlos E, Risueño RM, Laronde S, et al (2012). Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell, 149, 1284-97.
23. Solomon KR, Freeman MR (2008). Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrin Met, 19, 113-21.
24. Steinkopf S, Schelderup AK, Gjerde HL, et al (2008). The psychotropic drug olanzapine (Zyprexa) increases the area of acid glycerophospholipid monolayers. Biophys Chem, 134, 39-46.
25. Suwalsky M, Villena F, Sotomayor CP, et al (2008). Human cells and cell membrane molecular models are affected in vitro by chlorpromazine. Biophys Chem, 135, 7-13.
26. Wiklund ED, Catts VS, Catts SV, et al (2010). Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target. Int J Cancer, 126, 28-40.
27. Wuonola MA, Palfreyman MG, Motohashi N, et al (1998). The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm. Anticancer Res, 18, 337-48.
28. Yeh CT, Wu ATH, Chang PMH, et al (2012). Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med, 186, 1180-8.
29. Zhelev Z, Ohba H, Bakalova R, et al (2004). Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines Leukemia Cancer Chemother Pharmacol, 53, 267-75.